뉴로네틱스 (STIM) 주가

뉴로네틱스(STIM)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $3.30 (+8.91%), 시가총액 $0.08B, 52주 범위 $1.18 ~ $4.66.

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to ex

핵심 지표

• 현재가: $3.30 (+8.91%)
• 시가총액: $0.08B
• 52주 최저~최고: $1.18 ~ $4.66
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NASDAQ

뉴로네틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

뉴로네틱스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 6.19
• 순이익률: -0.24%
• 영업이익률: -0.26%

자주 묻는 질문